Matthew R. Guthrie - Concepedia

Author

Matthew R. Guthrie

Also Known As

M. Guthrie, M.R. Guthrie, Marin Guthrie, Matthew Guthrie, Matthew R. Guthrie

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Matthew R. Guthrie is an author at Huntsman Cancer Institute specializing in cancer genetics, medicine, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	1.1K
2	Cell Biology	2	2	1.1K
3	Cancer Genetics	2	2	1.1K
4	Cancer Biology	2	2	1.1K
5	Tumor Biology	1	1	570

Matthew R. Guthrie

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition Gürkan Mollaoglu, Matthew R. Guthrie, Stefanie Böhm, Cancer Cell Variant Neuroendocrine SubtypeAurora Kinase InhibitionOncogenic AgentMedicineBronchial Neoplasm	2017	570
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate Abbie S. Ireland, Alexi M. Micinski, David W. Kastner, Cancer Cell Neuroendocrine FateOncogenic AgentMedicineCancer BiologyCell Biology	2020	496
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion Milind D. Chalishazar, Sarah J. Wait, Fang Huang, Clinical Cancer Research	2019	173
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies Robert J. Cardnell, Lerong Li, Triparna Sen, Oncotarget	2017	91
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer Marcel A. Dammert, Johannes Brägelmann, Rachelle R. Olsen, Nature Communications	2019	83
ASCL1 represses a SOX9 <sup>+</sup> neural crest stem-like state in small cell lung cancer Rachelle R. Olsen, Abbie S. Ireland, David W. Kastner, Genes & Development	2021	72

Page 1